Default company panoramic image

Smart Therapeutics

Bio Pharmaceutical firm with new drug platform, 15 drugs in the pipeline and $9million in public grants to date, seeking $10mm for FDA tests

  • Stage Product In Development
  • Industry Biotechnology
  • Location Boca Raton, FL, USA
  • Currency USD
  • Founded June 2011

Company Summary

We are a leading biotechnology company focused on the discovery, development and commercialization of an exciting new class of proprietary, orally-administered drugs that treat a broad range of diseases by selectively targeting and modulating RNA. Market Opportunity RNA represents one of the most promising new areas of research of the 21st century. A virtually unlimited number of opportunities exist for the discovery of new drugs that target RNA.


  • Default avatar
    Joseph Scime

    25 years of senior management experience serving as the Chief Executive Officer, Chief Operating Officer and Corporate Director for public and private companies operating in such industries as healthcare, pharmaceutical and investment banking, including US Diagnostic Labs, Inc., a life sciences company, and Belmac Corp, an international pharmaceutical company. Mr. Scime is widely recognized for his expertise with Investor Relations, IPOs, Mergers

  • Default avatar
    Alex Andre

    Visionary, entrepreneurial-minded executive possessing a rare combination of business, legal & financial expertise acquired over a 15-year career as the CFO and General Counsel of public & private companies, an accountant at a Big 4 accounting firm, and a corporate & securities attorney at major national law firms. Results-oriented leader utilizing keen analysis, insights and team aproach to drive organizational improvements and implementation of

  • Default avatar
    Matthew Disney
    Co-Founder, Consultant

    Dr. Matthew D. Disney is one of our Co-Founders, is the Co-inventor of our SMaRT technology, and serves as one of our consultants and as a member of our Advisory Board. Dr. Disney is overseeing the research and development of our technology and small-molecule drugs at The Scripps Research Institute in Florida, where he serves as an Associate Professor in the Department of Chemistry. Dr. Disney has acquired more than 15 years of experience in the